Tumor volume determines the feasibility of cell‐free DNA sequencing for mutation detection in non‐small cell lung cancer

Next‐generation sequencing (NGS) and digital PCR technologies allow analysis of the mutational profile of circulating cell‐free DNA (cfDNA) in individuals with advanced lung cancer. We have now evaluated the feasibility of cfDNA sequencing for mutation detection in patients with non‐small cell lung...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancer Sci
Autori principali: Ohira, Tatsuo, Sakai, Kazuko, Matsubayashi, Jun, Kajiwara, Naohiro, Kakihana, Masatoshi, Hagiwara, Masaru, Hibi, Masaaki, Yoshida, Koichi, Maeda, Junichi, Ohtani, Keishi, Nagao, Toshitaka, Nishio, Kazuto, Ikeda, Norihiko
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2016
Soggetti:
Original Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5132294/
https://ncbi.nlm.nih.gov/pubmed/27575703
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13068
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi